Forte Biosciences (FBRX) Misses Q3 EPS by 433c

Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($4.54), $4.33 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• BofA Securities Starts Mobility Global (MBGL) at Neutral
• Truist Securities Starts Matthews International (MATW) at Hold, 'We see risk/reward as more balanced'